AVGO
42
-2
GILD
63
-4
VTR
60
5
URI
52
4
FLR
43
10
ALL
50
-7
FOXA
69
2
UPS
33
3
NOC
35
-2
AON
75
-3
SLB
55
2
HBI
31
-6
ADT
38
3
XOM
42
3
AFL
44
-2
MSI
35
-11
D
40
-3
MPC
44
5
SRE
56
2
KMX
70
5
AVGO
42
-2
GILD
63
-4
VTR
60
5
URI
52
4
FLR
43
10
ALL
50
-7
FOXA
69
2
UPS
33
3
NOC
35
-2
AON
75
-3
SLB
55
2
HBI
31
-6
ADT
38
3
XOM
42
3
AFL
44
-2
MSI
35
-11
D
40
-3
MPC
44
5
SRE
56
2
KMX
70
5
Financhill
Back

Citizens Financial Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
60

CFG
Citizens Financial Group

Last Price:
$46.81
Seasonality Move:
-7.53%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
60
Citizens Financial Group (CFG) is a Buy

Is Citizens Financial Group a Buy, Sell or Hold?

  • The current Citizens Financial Group [CFG] share price is $46.35. The Score for CFG is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CFG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CFG Stock Price Chart

What is Citizens Financial Group's stock price today?

  • The Citizens Financial Group share price today is $46.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFG is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 47.75 Sell
Chaikin Money Flow: -970581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.77 - 48.11) Sell
Bollinger Bands (100): (42.14 - 47.26) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

CFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.12 Sell
20-day SMA: 47.33 Sell
50-day SMA: 45.89 Buy
200-day SMA: 41.41 Buy
8-day EMA: 46.8 Sell
20-day EMA: 46.83 Sell
50-day EMA: 46.09 Buy
200-day EMA: 41.9 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Citizens Financial Group Earnings Growth & CFG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $1.13 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Citizens Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):